SOLVING
YOUR
CHALLENGES
TO DRIVE RESULTS
Increasing competition, lack of awareness and identifying and reaching the right patients are among the many daunting challenges when bringing a rare disease treatment to market today. With experience serving 147 rare disease brands across 18 years, EVERSANA INTOUCH is a strategic partner that understands and helps pharmaceutical organizations navigate the interconnected complexities of rare disease to build maximum brand impact.
- High-science expertise
- Deep experience in rare
- Predictive analytics
- Patient and HCP identification
- Personalized experiences
- Empathetic storytelling
Entering a crowded market with an expedited launch timeline, we needed our UCB US Rare Disease portfolio to break through to reach even more patients and providers with UCB’s solutions. We turned to our agency partner for their expertise to engage our audiences based on key audience insights informed by data.
EVERSANA INTOUCH supported UCB in launching a dynamic campaign that not only stood out but also helped us make a significant impact for our brands.”
– Kimberly Moran, Head, US Rare Diseases, UCB, Inc.
Duchenne Muscular Dystrophy
How we unleashed kids’ inner animals to fight against Duchenne
VIEW CASE STUDYKORLYM: Cushing Syndrome
Calling out the true villain behind hard-to-control blood sugar for hypercortisolism
See how we used Artful Ingenuity to drive results for Korlym below
Please Provide Your Information To Download The Korlym Case Study